Oliver Hahn

722 total citations
28 papers, 287 citations indexed

About

Oliver Hahn is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Oliver Hahn has authored 28 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Oliver Hahn's work include Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Oliver Hahn is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Oliver Hahn collaborates with scholars based in Germany, United States and Canada. Oliver Hahn's co-authors include J. Fricke, Rainer Hofmann, Harald Mehling, Ove Nilsson, F. Raether, Arne Strauß, Lutz Trojan, Niklas Klümper, René Müller‐Wille and Charis Kalogirou and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Oliver Hahn

23 papers receiving 275 citations

Peers

Countries citing papers authored by Oliver Hahn

Since Specialization

Citations

This map shows the geographic impact of Oliver Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Hahn more than expected).

Fields of papers citing papers by Oliver Hahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Hahn. The network helps show where Oliver Hahn may publish in the future.

Co-authorship network of co-authors of Oliver Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Hahn. A scholar is included among the top collaborators of Oliver Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Hahn. Oliver Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial transcriptomic profiling of metastatic renal cell carcinoma identifies chemokine-driven macrophage and CD8+ T-cell interactions predictive of immunotherapy response 2025 ·Journal for ImmunoTherapy of Cancer ·Charis Kalogirou, Markus Krebs, Andreas Steven Kunz, Oliver Hahn, Hubert Kübler, (unknown), Arndt Hartmann, Astrid Schmieder, Markus Eckstein	0
2	Scene-Centric Unsupervised Panoptic Segmentation 2025 ·TUbilio (Technical University of Darmstadt) ·Oliver Hahn, (unknown), (unknown), Daniel Cremers, Christian Rupprecht, S. Roth	0
3	Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer 2024 ·Cancer Medicine ·(unknown), (unknown), (unknown), (unknown), Damian J. Ralser, Marieta Toma, Glen Kristiansen, Oliver Hahn, Sabrina Zechel, Viktor Grünwald, Tobias Bald, (unknown), Torsten Pietsch, Manuel Ritter, (unknown), Markus Eckstein, (unknown), Philipp Krausewitz, Niklas Klümper	3
4	First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany 2024 ·Clinical Genitourinary Cancer ·Cristina Cano Garcia, Benedikt Hoeh, (unknown), Séverine Banek, Niklas Klümper, (unknown), Oliver Hahn, (unknown), Jörg Ellinger, (unknown), (unknown), (unknown), Friedemann Zengerling, Kati Erdmann, (unknown), Charis Kalogirou, (unknown)	3
5	openLAB – Eine Forschungsbrücke zur Entwicklung eines digitalen Brückenzwillings 2024 ·Beton- und Stahlbetonbau ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Oliver Hahn, Frank Jesse, Kay Smarsly, Steffen Marx	6
6	Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort 2024 ·Urologia Internationalis ·(unknown), Cristina Cano Garcia, Niklas Klümper, (unknown), Oliver Hahn, Kerstin Junker, Kati Erdmann, (unknown), (unknown), Friedemann Zengerling, Séverine Banek, Jörg Ellinger, (unknown), Johannes Huber, Charis Kalogirou, Philip Zeuschner, Benedikt Hoeh	1
7	A Perspective on Deep Vision Performance with Standard Image and Video Codecs 2024 ·(unknown), Oliver Hahn, Daniel Cremers, S. Roth, Biplob Debnath	0
8	Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions 2023 ·Clinical & Translational Immunology ·Benedikt Hoeh, Cristina Cano Garcia, Séverine Banek, Niklas Klümper, (unknown), Jörg Ellinger, (unknown), Oliver Hahn, (unknown), Friedemann Zengerling, (unknown), Kati Erdmann, (unknown), (unknown), Johannes Huber, Charis Kalogirou, Philip Zeuschner	7
9	The influence of secondary resection using NeuroSAFE-technique on sexual function in unilateral nerve-sparing robot-assisted laparoscopic prostatectomies 2023 ·Scandinavian Journal of Urology ·(unknown), Annemarie Uhlig, (unknown), Oliver Hahn, Lutz Trojan, (unknown)	1
10	Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort 2022 ·Urologia Internationalis ·Benedikt Hoeh, (unknown), Niklas Klümper, Oliver Hahn, Philip Zeuschner, Séverine Banek, Pierre I. Karakiewicz, Jörg Ellinger, Julia Heinzelbecker, Michael Hölzel, Arne Strauß, Friedemann Zengerling, (unknown), Charis Kalogirou	7
11	Einsatz einer stützenden Herrenunterhose bei elektiven skrotalen Eingriffen 2022 ·GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) ·(unknown), Arne Strauß, Annemarie Uhlig, Oliver Hahn, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lutz Trojan, (unknown), (unknown)	0
12	CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo 2021 ·Cancer Gene Therapy ·(unknown), Derya Tilki, (unknown), Anna Suling, Oliver Hahn, Pierre Tennstedt, Christiane Matuszcak, Hanna Maar, Vera Labitzky, (unknown), (unknown), Simon J. Baumgart, Steven A. Johnsen, Martina Kluth, Hüseyin Sirma, Ronald Simon, Guido Sauter, Hartwig Huland, Udo Schumacher, Tobias Lange	7
13	Modulating the Heat Sensitivity of Prostate Cancer Cell Lines In Vitro: A New Impact for Focal Therapies 2020 ·Biomedicines ·Oliver Hahn, (unknown), (unknown), (unknown), (unknown), Paul Thelen, (unknown), Stefan Duensing, Sascha Pahernik, Lutz Trojan, Ionel Valentin Popeneciu	5
14	Stone-Free Rate after Treating Kidney Stones Exceeding 10 mm via Flexible Ureteroscopy: Can Endoscopic Assessment Replace Low-Dose Computed Tomography Control? 2019 ·Urologia Internationalis ·Konrad Wilhelm, Oliver Hahn, Martin Schoenthaler, Simon Hein, Jakob Neubauer, Marco J. Schnabel, Andreas Neisius	7
15	Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer 2018 ·Scientific Reports ·Tobias Lange, (unknown), Simon A. Joosse, Klaus Pantel, Oliver Hahn, (unknown), Sergey A. Dyshlovoy, Jasmin Wellbrock, Susanne Feldhaus, Hanna Maar, (unknown), Martina Kluth, Ronald Simon, Thorsten Schlomm, Hartwig Huland, Udo Schumacher	19
16	Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy 2017 ·CardioVascular and Interventional Radiology ·Annemarie Uhlig, Oliver Hahn, Arne Strauß, Joachim Lotz, Lutz Trojan, René Müller‐Wille, Johannes Uhlig	15
17	Galileo's Sidereus nuncius : a comparison of the proof copy (New York) with other paradigmatic copies 2011 ·Akademie Verlag eBooks ·(unknown), Oliver Hahn	2
18	Arabisches Satelliten-Nachrichtenfernsehen. Entwicklungsgeschichte, Strukturen und Folgen für die Konfliktberichterstattung aus dem Nahen und Mittleren Osten 2005 ·Medien & Kommunikationswissenschaft ·Oliver Hahn	2
19	Thermal Diffusivity of Semitransparent Materials Determined by the Laser-Flash Method Applying a New Analytical Model 1998 ·International Journal of Thermophysics ·Harald Mehling, (unknown), Ove Nilsson, J. Fricke, Rainer Hofmann, Oliver Hahn	135
20	Determination of thermal diffusivity in diathermic materials by the laser-flash technique 1997 ·High Temperatures-High Pressures ·Rainer Hofmann, Oliver Hahn, F. Raether, Harald Mehling, J. Fricke	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact